Schedule 13D ownership disclosure

ADVERUM BIOTECHNOLOGIES INC

Security class unavailable · CUSIP: 00773U108

Event date: 2021-03-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,052,068
Percent of class
6.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013594-21-000276
Form type
SC 13D
Filer
Adverum Biotechnologies, Inc.
CIK
CIK 1501756
Filed
Mar 18, 2021
Reporting period
Mar 15, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub